Skip to Main Content

Medtronic plc

MDT Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

$MDT is featured in our Shelley Moore Capito and Dan Meuser strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MDT by members of U.S. Congress

Politician Type Traded
Julie Johnson House / D Sale $1,001 - $15,000 Aug 14, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jun 27, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 May 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 23, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 15, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Apr 08, 2025
George Whitesides House / D Sale $50,001 - $100,000 Mar 24, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Mar 20, 2025
Bruce Westerman House / R Purchase $1,001 - $15,000 Mar 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 28, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 28, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Feb 25, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 19, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 22, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Emily Randall House / D Sale $1,001 - $15,000 Jan 06, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Sale $1,001 - $15,000 N/A
John James House / R Sale $1,001 - $15,000 Sep 04, 2024
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Aug 26, 2024
Earl Blumenauer House / D Sale $1,001 - $15,000 Jul 09, 2024
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul 02, 2024
John James House / R Purchase $1,001 - $15,000 Jun 18, 2024
John James House / R Sale $1,001 - $15,000 Jun 03, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Feb 13, 2024
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Feb 09, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan 23, 2024
Kathy E. Manning House / D Purchase $15,001 - $50,000 Jan 23, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan 23, 2024
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec 28, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec 12, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec 12, 2023
Kathy E. Manning House / D Sale $15,001 - $50,000 Dec 12, 2023
Debbie Dingell House / D Purchase $15,001 - $50,000 Dec 05, 2023
John James House / R Purchase $1,001 - $15,000 Nov 10, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct 24, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Oct 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 02, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep 26, 2023
Pete Ricketts Senate / R Sale (Full) $50,001 - $100,000 Sep 21, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 13, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 13, 2023
Michael Guest House / R Purchase $1,001 - $15,000 Aug 07, 2023
Pete Sessions House / R Sale $15,001 - $50,000 Jun 15, 2023
MDT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MDT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in MDT holdings by institutional investors

Quarterly net insider trading by MDT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

MDT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

MDT Revenue by Segment or Geography

By Segment
By Geography
MDT Income Statement
MDT Balance Sheet
MDT Cash Flow
U.S. Patents

New MDT patent grants

  • Patent Title: Implantable cardiac monitor Apr. 15, 2025
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Dec. 17, 2024
  • Patent Title: Implantable pump controller Oct. 15, 2024
  • Patent Title: Plunger Sep. 17, 2024
  • Patent Title: Plunger Jun. 25, 2024
  • Patent Title: Implantable cardiac monitor May. 28, 2024
  • Patent Title: Handle for a medical tool May. 21, 2024
  • Patent Title: Plunger Jan. 02, 2024
  • Patent Title: Tool handle Dec. 05, 2023
  • Patent Title: Implantable cardiac monitor Aug. 29, 2023
  • Patent Title: Implantable cardiac monitor Aug. 29, 2023
  • Patent Title: Tool handle Feb. 28, 2023
  • Patent Title: Plunger Jan. 24, 2023
  • Patent Title: Incision tool Oct. 18, 2022
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Aug. 16, 2022
  • Patent Title: Implantable cardiac monitor Jul. 12, 2022
  • Patent Title: Docking station of a recharger for an internal neural stimulator Jul. 05, 2022
  • Patent Title: Tibial implantable neurostimulator with suture loop May. 24, 2022
  • Patent Title: Tibial implantable neurostimulator May. 24, 2022
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Mar. 15, 2022
  • Patent Title: Implantable medical device Mar. 08, 2022
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Mar. 08, 2022
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Feb. 22, 2022
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Feb. 22, 2022
  • Patent Title: Recharger of an internal neuralstimulator Nov. 30, 2021
  • Patent Title: Display screen or portion thereof with graphical user interface Sep. 14, 2021
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Aug. 17, 2021
  • Patent Title: Tool for adjusting an implantable adjustable fluid flow control valve Jun. 15, 2021
  • Patent Title: Systems and methods for leadless cardiac resynchronization therapy Nov. 24, 2020
  • Patent Title: Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing Sep. 08, 2020
  • Patent Title: System and method for controlling cardiac pacing mode switching Jun. 19, 2018
  • Patent Title: Optical trigger for therapy delivery Jun. 19, 2018
  • Patent Title: Resonance tuning module for implantable devices and leads Jun. 19, 2018
  • Patent Title: Embolic protection device Jun. 19, 2018
  • Patent Title: Intelligent discovery of medical devices by a programming system Jun. 12, 2018
  • Patent Title: Medical device delivery system Jun. 12, 2018
  • Patent Title: Implantable medical elongated member including a tissue receiving fixation cavity Jun. 12, 2018
  • Patent Title: Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead Jun. 12, 2018
  • Patent Title: Noninvasive cardiac therapy evaluation Jun. 12, 2018
  • Patent Title: Methods, devices, and systems for communicating with an implantable medical device of a last far field communication session during a subsequent far field communication session while using a same session key Jun. 05, 2018
  • Patent Title: Methods, devices, and systems for communicating with an implantable medical device of a last far field communication session during a subsequent far field communication session while using a same session key Jun. 05, 2018
  • Patent Title: Medical devices and methods for delivery of current-based electrical stimulation therapy Jun. 05, 2018
  • Patent Title: Tine fixation components for implantable medical devices Jun. 05, 2018
  • Patent Title: Noninvasive cardiac therapy evaluation Jun. 05, 2018
  • Patent Title: Medical cable connector for a medical lead providing an electrical receptacle that is movable relative to an outer body May. 29, 2018
  • Patent Title: Means and method of replacing a heart valve in a minimally invasive manner Mar. 12, 2013
  • Patent Title: World wide patient location and data telemetry system for implantable medical devices Nov. 15, 2011
  • Patent Title: Rf coupled, implantable medical device with rechargeable back-up power source Sep. 06, 2011
  • Patent Title: Valve holder for tricuspid heart valve May. 24, 2011
  • Patent Title: Medical device slitter Jan. 12, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to MDT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
MDT News

Recent insights relating to MDT

CNBC Recommendations

Recent picks made for MDT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDT

MDT Analyst Ratings

MDT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MDT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MDT stock a Buy, Sell, or Hold?

  • What is the price target for $MDT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MDT Top Shareholders
Shareholder
Shares Held
MDT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MDT stock?

  • Who owns the most shares of $MDT stock?

  • What funds own $MDT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MDT

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Back To Top